Full-Time

Customer Success Manager

EHR, Revenue Cycle Management

Posted on 9/5/2025

Osmind

Osmind

51-200 employees

Mental health EMR platform with billing

Compensation Overview

$85k - $135k/yr

San Francisco, CA, USA

Hybrid

Hybrid position requiring some in-office presence.

Category
Sales & Account Management
Requirements
  • Minimum 3-5 years’ experience in healthcare practice operations working in independent practices.
  • Direct experience with Revenue Cycle Management (RCM) processes and electronic health record (EHR) systems.
  • Proven track record in customer success, client relationship management, or practice consulting roles.
  • Strong communication skills with the ability to convey complex operational concepts clearly to clinical and administrative stakeholders.
  • Demonstrated ability to handle multiple clients or projects simultaneously with minimal supervision.
  • Proficiency in using software platforms for communication, project management, and reporting.
  • A patient-first mindset with a passion for improving clinician workflows and patient outcomes.
Responsibilities
  • Serve as the trusted operational advisor for assigned clinical practices using the O360 product and RCM services.
  • Assist clinicians and practice staff in understanding and optimizing workflows supported by our EHR and RCM tools.
  • Proactively identify and troubleshoot practice operational challenges affecting patient care and revenue cycle processes.
  • Collaborate cross-functionally with Product, Support, Implementation, and RCM teams to ensure issues are resolved promptly and improvements are communicated.
  • Deliver tailored training and enablement sessions focused on operational excellence and product utilization.
  • Manage ongoing client relationships to drive product adoption, satisfaction, and retention.
  • Partner with practices on expansion opportunities including new treatment modalities (TMS, Spravato, ketamine) and capacity optimization.
  • Gather and relay customer feedback to inform continuous product enhancement.
  • Track and report concrete improvements in practice performance metrics, demonstrating clear return on Osmind 360 investment within 6 months post go-live.
  • Provide detailed reporting to the Customer Success Lead on the health and performance of assigned practices.
  • Operate autonomously, prioritizing workload and managing time effectively to meet client and company expectations.
Desired Qualifications
  • You've worked with or at a behavioral health private practice leveraging modalities like Spravato and TMS.
  • Track record in practice growth strategy or business development within healthcare.
  • Knowledge of data analytics related to practice operations or financial performance.

Osmind provides an EMR platform tailored for mental health professionals, including psychiatrists and therapists. It combines billing, scheduling, patient engagement, intake forms, and automated outcome measures in one easy-to-use system. The service is offered on a subscription basis, plus a flat-rate patient payment option with no per-transaction fees to streamline workflows. Its goal is to help clinicians deliver care more efficiently and increase patient access to innovative treatments.

Company Size

51-200

Company Stage

Series B

Total Funding

$57.1M

Headquarters

San Francisco, California

Founded

2020

Simplify Jobs

Simplify's Take

What believers are saying

  • Compass Pathways collaboration prepares clinics for FDA-approved psychedelics.
  • CareNet GPO partnership delivers SPRAVATO savings to 1,000+ practices.
  • Cybin partnership accelerates commercial rollout using Osmind's data platform.

What critics are saying

  • Epic's Canto module captures 60% psychiatry EHR market within 24 months.
  • Headspace acquires Power, eroding Osmind's share in 6-12 months.
  • FDA denies COMP360 approval, wasting Osmind's psychedelic R&D investments.

What makes Osmind unique

  • Osmind's EHR tailors workflows for ketamine, Spravato, TMS, and psychedelic therapies.
  • Osmind aggregates two million patient outcomes for real-world ketamine analyses.
  • Osmind networks over 1,000 independent interventional psychiatry practices nationwide.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Professional Development Budget

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

-4%

2 year growth

-4%
Postmedia Network
Apr 21st, 2025
Cybin Partners with Osmind to Accelerate Commercial Preparation for its Clinical-Stage Psychiatry Programs

Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) ("Cybin" or the "Company"), a clinical-stage breakthrough neuropsychiatry company committed to revolutionizing mental healthcare by developing new and innovative next-generation treatment options, today announced a strategic partnership with Osmind, a leading service provider advancing psychiatry through technology, services, and real-world evidence to bring innovative mental health treatments to patients in need.

Business Wire
May 2nd, 2024
Osmind Announces Collaboration with the American Psychiatric Association to Advance Quality Psychiatric Care and Accelerate Research

Osmind announces collaboration with the American Psychiatric Association to advance quality psychiatric care and accelerate research.

Business Wire
May 2nd, 2024
Osmind Announces Collaboration With The American Psychiatric Association To Advance Quality Psychiatric Care And Accelerate Research

SAN FRANCISCO--(BUSINESS WIRE)--Today, Osmind, the leading psychiatric treatment and research platform, announced an innovative collaboration with the American Psychiatric Association (APA) to improve the adoption of measurement-based care (MBC) and precision treatment in psychiatry. This collaboration between Osmind and APA’s PsychPRO registry intends to broaden access to personalized care, improve patient outcomes, generate robust real-world evidence (RWE) and accelerate psychiatry’s evolution to precision medicine. PsychPRO registry is a clinical data registry that enables the collection and analysis of clinical data to advance quality improvement efforts and accelerate research for the psychiatric community. "At Osmind, we emphasize the importance of clinicians participating in evidence-generating medicine to help shape the future of mental health care, especially as the psychiatric field begins to embrace new treatments and precision psychiatry,” said Carlene MacMillan, MD, Chief Medical Officer of Osmind. “Clinicians in private practice juggle many competing demands so it is crucial we make participation both easy and worthwhile to them.". Osmind is integrating a number of APA’s diagnostic and outcomes measures of interest, including the DSM-5-TR Self-Rated Level 1 Cross-Cutting Symptom Measure developed by APA researchers, into its electronic health record (EHR) software

Cision
Dec 5th, 2023
Osmind Announces Virtual 2023 Breakthrough Mental Health Treatment Forum To Advance Mental Health Research, Treatment, And Community

Starting today, mental health clinicians, practice owners, and researchers have free access to sessions led by the nation's foremost mental health clinicians driving breakthrough medicineSAN FRANCISCO, Dec. 5, 2023 /PRNewswire-PRWeb/ -- Osmind, the public benefit corporation helping clinicians and researchers advance life-saving mental health treatment, today announced its inaugural Breakthrough Mental Health Treatment Forum is now open to virtual attendees. Sessions will focus on mental health treatment research, how to build a successful practice, and the value of community in delivering care. The forum brings together psychiatrists, nurse practitioners, psychotherapists, scientists, clinicians, mental health practice leaders and administrators, and academics all dedicated to advancing therapeutic options for people facing severe and treatment-resistant mental illness."The mental health crisis continues to grow, yet critical advancements in psychiatric treatment are lagging behind," said Lucia Huang, co-founder and CEO of Osmind. "This forum is a unique space for those on the leading edge of novel therapeutic care to hear from leaders driving future innovations on the frontlines of breakthrough mental health care, helping more patients access effective care, and supporting future collaborations."The three-day forum will run from Tuesday, December 5 through Thursday, December 7. Content is available asynchronously

The Manchester Times
Oct 24th, 2023
Osmind Reimagines Insurance Reimbursement for Psychiatric Clinicians, Expanding Patient Access to Mental Health Care

Osmind, the public benefit corporation helping clinicians and researchers advance life-saving mental health treatment, today announced Osmind Claims, which introduces new billing capabilities purpose-built to simplify insurance reimbursement for psychiatric treatment, enabling greater access to insurance-supported mental health care.

INACTIVE